HIV News and Research

RSS

Unique variant of HIV that is resistant to multiple classes of antiretroviral drugs

Researchers have identified a patient with a unique variant of HIV that is resistant to multiple classes of antiretroviral drugs and associated with the rapid development of AIDS, reporting their findings in this week’s issue of The Lancet.

21 Mar 2005

10% of homosexual men diagnosed late died within a year

1 in 4 HIV-infected homosexual men in England and Wales were diagnosed late in 2001 and 10% died within a year compared to only 0.5% of those not diagnosed late - reports a recent AIDS journal article

17 Mar 2005

New set of standards to improve sexual health services in the NHS

A new set of clear recommended standards to improve sexual health services in the NHS have been jointly launched today by Public Health Minister Melanie Johnson and Ruth Lowbury of the Medical Foundation for AIDS and Sexual Health.

16 Mar 2005

Are sources of affordable generic medicines drying up?

India should ensure global access to medicines when implementing its patent law.

16 Mar 2005

Antiretroviral therapy may prevent some cancers in people with HIV

In people infected with human immunodeficiency virus (HIV), highly active antiretroviral therapy (HAART) may prevent most excess cases of Kaposi sarcoma and non-Hodgkin lymphoma, according to a new study in the March 16 issue of the Journal of the National Cancer Institute.

15 Mar 2005

Innovative computer modeling technique predicts how protein molecule behavior in response to environmental conditions

In a development that could have great significance for efforts to understand how the basic molecular machinery of life works, researchers at the University of Texas Medical Branch at Galveston (UTMB) have successfully applied an innovative computer modeling technique to predicting how protein molecules will behave in response to different environmental conditions.

15 Mar 2005

New study reveals little risk in insuring HIV positive patients

The Dutch Association of Insurers has announced the results of a study revealing there is little risk in providing life insurance policies to HIV patients in the Netherlands undergoing Highly Active Antiretroviral Therapy (HAART).

15 Mar 2005

Gene therapy helps Lou Gehrig's disease

The most common form of motor neurone disease, called amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, is caused when neurones in the spinal cord die, leading to muscle wasting and total paralysis.

14 Mar 2005

HIV-1 spread through six transmission lines in the UK

Contrary to the prevailing belief that the HIV epidemic in the UK can be traced back to one source, a new study suggests that HIV spread via at least six independent virus introductions and subsequent transmission chains.

14 Mar 2005

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

A public clinic offering antiretroviral (ARV) treatment to people with HIV/AIDS, recently established in Botswana, has had its share of trials and errors. However, the obstacles it has encountered - and has largely overcome - can serve as valuable lessons for other developing countries trying to launch their own treatment programs, according to an article in the March 15 issue of Clinical Infectious Diseases.

14 Mar 2005

Naturally occurring antifungal agent in saliva kills oral pathogen responsible for most HIV-related oral infections

Oral biologists at the University at Buffalo have shown for the first time how histatin, the naturally occurring antifungal agent in saliva, kills the oral pathogen Candida albicans, the fungus responsible for most HIV-related oral infections.

14 Mar 2005

Research could lead to new drugs that combat HIV infection by shutting down the virus's assembly lines

After infecting a susceptible cell, the human immunodeficiency virus hijacks that cell's normal machinery to produce carbon copies of itself. New HIV particles roll off the cellular assembly lines, burst like bubbles out of the cell, and float off to invade other cellular factories.

14 Mar 2005

HIV on the rise through hetero sex

The number of people developing HIV infections through heterosexual intercourse in the United Kingdom is rising.

13 Mar 2005

China trials new HIV vaccine on humans

China which has 840,000 people with HIV, a conservative estimate say experts, will carry out the very first trials of a new virus on human guinea pigs.

13 Mar 2005

Biologists discover why 10% of Europeans are safe from HIV infection

Scientists have known for some time that these individuals carry a genetic mutation (known as CCR5-Ä32) that prevents the virus from entering the cells of the immune system but have been unable to account for the high levels of the gene in Scandinavia and relatively low levels in areas bordering the Mediterranean.

9 Mar 2005

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

A public clinic offering antiretroviral (ARV) treatment to people with HIV/AIDS, recently established in Botswana, has had its share of trials and errors.

9 Mar 2005

Study examines consequences of Thailand's "War on Drugs"

Researchers from the Johns Hopkins Bloomberg School of Public Health, the Chiang Mai University Research Institute for Health Sciences and the Northern Drug Treatment Centre in Thailand conducted the first study on the effect of Thailand’s aggressive war on illicit drugs and the war’s impact on injection drug users.

9 Mar 2005

HIV is not an independent risk factor for severe heart disease

Infection with human immunodeficiency virus (HIV) is no longer an automatic death sentence, thanks to the use of highly active anti-retroviral therapy (HAART).

8 Mar 2005

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

The nation’s frontline HIV medical providers are calling for an end to waiting lists for essential anti-AIDS drugs that patients need in order to live.

8 Mar 2005

AIDS drug pricing complaint in South Africa against GlaxoSmithKline moves forward

A landmark South African legal complaint against British drug maker GlaxoSmithKline (GSK) over its AIDS drug pricing and policies in that country will proceed following an order late last week by South Africa's Competition Tribunal that will allow the complaint to go forward.

8 Mar 2005

HIV News and Research

Unique variant of HIV that is resistant to multiple classes of antiretroviral drugs

10% of homosexual men diagnosed late died within a year

New set of standards to improve sexual health services in the NHS

Are sources of affordable generic medicines drying up?

Antiretroviral therapy may prevent some cancers in people with HIV

Innovative computer modeling technique predicts how protein molecule behavior in response to environmental conditions

New study reveals little risk in insuring HIV positive patients

Gene therapy helps Lou Gehrig's disease

HIV-1 spread through six transmission lines in the UK

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

Naturally occurring antifungal agent in saliva kills oral pathogen responsible for most HIV-related oral infections

Research could lead to new drugs that combat HIV infection by shutting down the virus's assembly lines

HIV on the rise through hetero sex

China trials new HIV vaccine on humans

Biologists discover why 10% of Europeans are safe from HIV infection

Study examines lessons learned at Africa's first public antiretroviral treatment clinic

Study examines consequences of Thailand's "War on Drugs"

HIV is not an independent risk factor for severe heart disease

HIVMA and AAHIVM urge lawmakers to make medical care the top priority for Ryan White Programs

AIDS drug pricing complaint in South Africa against GlaxoSmithKline moves forward

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News